ClinicalTrials.gg
Enrolling by invitationNCT07119112Updated Nov 20, 2026

Evaluation of a Novel Drain Stripping Device for Reducing Surgical Drain Complications

An interventional study of Surgical drain stripping device and Standard of Care (Investigator Choice) in Surgical Drain, Abdominal Surgery Patients and Drains, sponsored by Mayo Clinic. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Other

How we know

Updated Nov 20, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research is to evaluate how well a novel surgical site drain tube clearing device works, and how easy it is for care staff to use.

Read the detailed description

The purpose of this research is to gather information on the ease of use, effectiveness, and potential ability to reduce post-surgical drain complications of a drain stripping device which was developed and made here at the Mayo Clinic. The device has been patented and has been tested in laboratory conditions, but it has not yet been evaluated by the FDA or cleared for marketing yet since it is a device that poses minimal risk to patients. The device is a plastic clamp which is used to move fluid through the drain tubing to keep the tubing clear and free flowing. The current method (standard of care) for doing this simply involves running fingers down the tubing to drain the fluid, which can be inadequate and sometimes physically challenging. The primary goal of the study is to get feedback from nurses using the device in a clinical setting. There are approximately 80 nurses working the hospital unit which cares for patients who may have a post-surgical drain emplaced. We will gather their feedback via an anonymous survey which will be available to the nurses on the Mayo Clinic Intranet. Secondary goals of the study attempt to ascertain the potential effect of device use upon patient outcomes. Inadequate draining of surgical site fluid can sometimes create the need for additional interventions, including surgical revisions. The drain stripping device used in this study, has been developed to address these issues. Preliminary bench testing in laboratory conditions has not indicated any reason to believe that use of the device to clear surgical drain tubing poses any greater (or even different) risk to patients than the current standard of care (using bare fingers). Patients are routinely sent home with one or more surgical drains which are cleared by the patient using the current standard of care. Therefore, there is no safety related need to start with a small number of study subjects as is typical for an initial trial; and since this is not a device or drug which would be likely to show obvious benefit within a small cohort, we are seeking data regarding potential effect of study device upon patient outcomes from 420 study subject encounters (210 in each arm - device use versus current standard of care), as opposed to the small numbers of subjects usually seen in initial clinical trials.

02

Conditions studied

  • Surgical Drain
  • Abdominal Surgery Patients
  • Drains

Keywords

  • Surgical Drain
  • Drain Tube Clearance
  • Drain Tube Occlusion
  • Drain Clearance Device
03

In context

Lead sponsor

Mayo Clinic is the lead sponsor of 3,272 studies on the registry; 672 are open to participants now.

Of its 452 completed or terminated interventional studies of FDA-regulated products, 322 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients aged 18 years or older, with no maximum age limit.
  • Patients undergoing surgical procedures that require the placement of Jackson-Pratt drains within the abdominal cavity.
  • Patients who are able to provide for participation in the study.
  • Mayo Clinic RNs caring for patients with post-surgical drains placed.

Exclusion criteria

Exclusion Criteria:

  • Patients under the age of 18.
  • Patients who do not have Jackson-Pratt drains placed post-operatively.
  • Patients with drains placed in locations other than the abdominal cavity.
  • Patients with known allergies or to the materials used in the drain stripping device.
  • Patients who are unable to provide due to cognitive impairments or any other reason.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Drain device user(s)

    Study participants whose caregivers are utilizing the drain device to clear surgical drain tubing.

    Device: Surgical drain stripping device

  • Other
    Control

    Study participants whose caregivers use the current standard of care for surgical drain tube stripping.

    Other: Standard of Care (Investigator Choice)

Interventions

  • DeviceSurgical drain stripping device

    We have developed a device to fully compress the surgical drain tubing without compromising the integrity of the tubing to clear the drain fluid/debris more effectively than the current standard of care.

  • OtherStandard of Care (Investigator Choice)

    Current standard of care for surgical drain tube stripping involves running fingertips down the length of the tubing compressing the drain tubing to clear fluid/debris.

06

What researchers measure

Primary outcomes

  1. Assess Ease of Use and Device Functionality Via Anonymous Survey

    Gather and analyze feedback from nurses regarding the ease of device use and the ability of the device to clear surgical drain tubing in the clinical setting via an anonymous survey which nurses may access within the Mayo Clinic intranet.

    Time frame: 1 year

Secondary outcomes

  1. Assess Effect Study Device May Have Upon Duration of Surgical Drain Placement

    Compare device use and standard of care group of study subjects for the amount of time their surgical drains remain in place to assess the potential ability of the surgical drain stripping device to reduce the time needed for a surgical drain to remain in place (in situ).

    Time frame: 1 year

  2. Assess Whether Device Reduces Surgical Drain Complications

    Compare clinical outcomes between device use and standard of care study subjects to assess whether or not the surgical drain tube stripping device leads to fewer drain associated post operative complications.

    Time frame: 1 year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — The primary study goal involves collecting device use feedback via an anonymous survey, and the secondary goals involve collecting and analyzing collective data. There would be no benefit to anyone to share individual study subject data, and we would not want to consider adding a patient privacy risk factor without obvious benefit.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Feb 2026 (actual). Primary completion is estimated for Nov 2027, 21 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: primary completion Aug 2026 → Nov 2027 and completion Jan 2027 → Nov 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 18, 2025
First posted
Aug 12, 2025
StartActual
Feb 20, 2026
Primary completionEst.
Nov 2027was Aug 2026
CompletionEst.
Nov 2027was Jan 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Aug 2026→Nov 2027
Nov 20, 2026
Study completion
Jan 2027→Nov 2027
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Primary completion Aug 2026→Nov 2027
    Study completion Jan 2027→Nov 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07119112
Lead sponsor
Mayo Clinic
Responsible party
Rob B. Hill (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Aug 12, 2025
Start date
Feb 20, 2026
Primary completion
Nov 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Robert Hill, APRN,CNP,MSN
principal investigator · Mayo Clinic
Michael Thorn, APRN,CNP,MSN
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion